- The key vendors in the Global Inflammatory Bowel Disease Market 2015-2019 are AbbVie Inc., Biogen Idec Inc., Janssen Pharmaceuticals Inc., Merck & Co. Inc., Shire plc and UCB SA
London, 10 April 2015: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the Global Inflammatory Bowel Disease Market 2015-2019. The dominance of the market by biologics used to treat patients suffering from the disease is one of the emerging trends in this market. Biologics are expected to become a preferred treatment option for the medical fraternity, patients, and the families of patients during the forecast period. This leads to a rise in the number of treatment-seeking patients, which increases the overall consumption of medicines. The Global Inflammatory Bowel Disease Market is expected to post a CAGR of 3.95% during the forecast period of 2014-2019.
“An increase in patient assistance programs initiated by various government and non-government organizations and major vendors to support patients suffering from inflammatory bowel disease propels the market growth,” says Faisal Ghaus, Vice President of Technavio Research.
“Patients have the option of applying to the patient assistance program of AbbVie for free medications or financial co-pay assistance for Humira. Janssen Pharmaceuticals through its JanssenAccessOne and RemiStart programs assists affected patients.”
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
If you are interested in more information on this topic and our upcoming research on the Global Inflammatory Bowel Disease Market 2015-2019; please send an e-mail to media@TechNavio.com
Follow us on Twitter @Technavio
Like us on Facebook
Follow us LinkedIn
Connect with us on Google+
